TAIHO PHARMACEUTICAL CO

taiho-pharmaceutical-co-logo

Taiho Pharmaceutical Co., Ltd. is engaged in the research, development, production, distribution, and marketing of pharmaceutical products. The company develops drugs primarily in the area of oncology. It also develops other pharmaceuticals, controlled medical devices, designated quasi-drugs, second-class OTC drugs, designated second-class OTC drugs, and third-class OTC drugs; S-1 for the treatment of gastric cancer; TAS-102 for the treatment of colorectal cancer; and anticancer agents for oncologists, other medical care professionals, and patients. In addition, it engages in the research and development in the areas of oncology,

#SimilarOrganizations #People #Financial #Website #More

TAIHO PHARMACEUTICAL CO

Social Links:

Industry:
Biopharma Biotechnology Medical Pharmaceutical

Founded:
1963-01-01

Address:
Tokyo, Tokyo, Japan

Country:
Japan

Website Url:
http://www.taiho.co.jp

Total Employee:
1001+

Status:
Active

Contact:
81 3 3294 4527

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Mobile Non Scaleable Content Nginx Euro IPv6 Cloudflare JS CDN JS DigiCert SSL


Similar Organizations

genome-pharmaceuticals-institute-logo

Genome Pharmaceuticals Institute

Genome Pharmaceuticals Institute Co. Ltd. is a

i2-pharmaceuticals-logo

i2 Pharmaceuticals

i2 Pharmaceuticals, a biopharmaceutical company.

taiwan-biotech-logo

Taiwan Biotech

Taiwan Biotech Co., Ltd. engages in the research, development.

teva-pharmaceutical-industries-logo

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.

Current Employees Featured

not_available_image

Teruhiro Utsugi
Teruhiro Utsugi Senior Managing Director @ Taiho Pharmaceutical Co
Senior Managing Director

not_available_image

Tatsuo Higuchi
Tatsuo Higuchi CEO @ Taiho Pharmaceutical Co
CEO

not_available_image

Masayuki Kobayashi
Masayuki Kobayashi President @ Taiho Pharmaceutical Co
President

Acquisitions List

Date Company Article Price
2022-05-11 Cullinan Pearl Cullinan Pearl acquired by Taiho Pharmaceutical Co 275 M USD

Investments List

Date Company Article Money raised
2019-09-24 AuB Taiho Pharmaceutical Co investment in Series A - AuB 300 M JPY
2018-02-27 Quentis Therapeutics Taiho Pharmaceutical Co investment in Series A - Quentis Therapeutics 48 M USD

Official Site Inspections

http://www.taiho.co.jp Semrush global rank: 188.07 K Semrush visits lastest month: 417.07 K

  • Host name: ec2-3-115-228-49.ap-northeast-1.compute.amazonaws.com
  • IP address: 3.115.228.49
  • Location: Tokyo Japan
  • Latitude: 35.6882
  • Longitude: 139.7532
  • Timezone: Asia/Tokyo
  • Postal: 102-0082

Loading ...

More informations about "Taiho Pharmaceutical Co" on Search Engine